1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Korean Association for the Study of Targeted Therapy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001) Poziotinib - HER2 Gene Mutation, Adenocarcinoma Lung Stage IV | Phase 2 | Completed | Korean Association for the Study of Targeted Therapy | 6 | 2016-10-01 | 2018-05-24 |
HM781-36B (1)
South Korea (1)